Please assess the completion status of the following clinical trial:

Trial Title: Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of restless legs syndrome with a total score of 15 or more points on the International RLS rating scale (IRLS).~* RLS symptoms interfering with sleep on 3 or more nights per week for at least 6 months.~* PSG confirmation of WASO of at least 60 min, PLMI of 10 or more, and total sleep time of at least 3 hrs and less than 6.5 hrs.~Exclusion Criteria:~* Secondary RLS.~* Daytime RLS symptoms requiring treatment.~* Primary sleep disorder.~* Sleep apnea.~* Night or shift work.~* Concurrent medical disorder that could interfere with efficacy assessment or present a safety concern.~* Pregnant or lactating women.~* Women of child-bearing potential not using acceptable method of birth control.~* Use of prohibited medication.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- pregabalin (Type: EXPERIMENTAL): None
- placebo (Type: PLACEBO_COMPARATOR): None
- pramipexole (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).